Watch the on-demand videos from the CURE® Educated Patient® Multiple Myeloma Summit, held virtually on November 13, 2022.
December 9th 2022
Watch Dr. Francesco Maura, Dr. Marcella Kaddoura and Mary DeRome answer questions about the future of myeloma during the CURE® Educated Patient® Multiple Myeloma Summit.
December 8th 2022
Watch Dr. Marcella Kaddoura, from Miami Sylvester Comprehensive Cancer Center, discuss targeting myeloma with small molecules with precision medicine during the CURE® Educated Patient® Multiple Myeloma Summit.
December 7th 2022
Watch Dr. Francesco Maura, from Miami Sylvester Comprehensive Cancer Center, discuss how personalized prediction models can be used to identify the best treatments during the CURE® Educated Patient Multiple Myeloma Summit.
December 6th 2022
Watch Valarie Traynham, of the HealthTree Foundation, discuss the long-term journey of the disease and disparities still seen during the CURE® Educated Patient® Multiple Myeloma Summit.
December 5th 2022
Watch Dr. Dickran Kazandjian and Dr. Benjamin Diamond answer questions about therapeutic options during the CURE® Educated Patient® Multiple Myeloma Summit.
December 4th 2022
Watch Dr. Benjamin T. Diamond, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss the role of sustained MRD negativity during the CURE® Educated Patient® Multiple Myeloma Summit.
December 3rd 2022
Watch Dr. Dickran Kazandjian, from the Sylvester Comprehensive Cancer Center at the University of Miami, discuss available immunotherapy options during the CURE® Educated Patient® Multiple Myeloma Summit.
December 2nd 2022
Watch Dr. C. Ola Landgren and Dr. David Coffey answer questions about novel treatments and the role of a healthy immune system during the CURE® Educated Patient® Multiple Myeloma Summit.
December 1st 2022
Watch Dr. David Coffey, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss the role of a healthy immune system during the CURE® Educated Patient® Multiple Myeloma Summit.
November 30th 2022
Watch Dr. C. Ola Landgren, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss novel treatments for newly diagnosed patients during the CURE® Educated Patient® Multiple Myeloma Summit.
Gimme Shelter from Lynch Syndrome
PD-L2 Biomarker May Predict Outcomes for Patients with ER-Positive Breast Cancer
Getting Back to Nature With Cancer
Tumor DNA May Predict Outcomes to Presurgical Treatment in Patients with Bladder Cancer